NA
Therapeutic Areas
Duopharma Biotech Bhd Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Omesec | Various therapeutic areas (generic) | Marketed |
| Prelica | Various therapeutic areas (generic) | Marketed |
| Biosimilar for anemia in chronic renal failure | Anemia associated with chronic renal failure | Marketed (Halal certified) |
Leadership Team at Duopharma Biotech Bhd
WA
Wan Amir-Jeffery Bin Wan Abdul Majid
Group Chief Executive Officer
PD
Priya Darshini A/P Asokan
Chief Innovation Officer
RR
Rohayu Rosnani Binti Mohd Adanan
Chief Financial Officer
KA
Krisnakumara-Reddi A/L Kesava-Reddi
Chief Manufacturing & Sustainability Officer